Login / Signup

Proton-pump inhibitor use and the development of new ischemic heart disease in non-cardiac chest pain patients.

Yeseong D KimStephen GanocyRonnie Fass
Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2020)
PPIs confer a statistically significant, but marginal effect on the risk of IHD development in NCCP patients. Thus, PPI use in NCCP only minimally alters the overall benign natural course of the disease.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • patient reported outcomes